LODOCO cpr 0.5 mg 30 pce

7680699310012 CH-69931 M04AC01 02.99.0.

Active substances:

No images available

Details

Product number
6993101
CPT
-
Packaging group
30
Unit
Tablette(n)
Composition
colchicinum 0.5 mg, lactosum monohydricum 88.87 mg, gelatina, solani amylum, talcum, magnesii stearas, pro compresso obducto.

Articles (1)

Lodoco 0.5 mg, Tabletten
Tabletten
30
View

Official Swissmedic V2 data

Additional information from the official database

Detailed composition

Substance Quantity Type Category
colchicinum
0.5 MG Substance Wirkstoff (Principe actif)
lactosum monohydricum
88.87 MG Substance HBESI
gelatina
- Substance HNIDK
solani amylum
- Substance HNIDK
talcum
- Substance HNIDK
magnesii stearas
- Substance HNIDK

Authorization holder

AGEPHA PHARMA s.r.o., Bratislava,

6300 Zug

Authorization information

Swissmedic authorization number
69931
Drug name
Lodoco, Tabletten
Galenic form
TAB
ATC Code
M04AC01
Authorization status
Z
Dispensation category
A
First authorization
01/04/2026
Authorization expiration date
31/03/2031
IT number
02.99.0.
Domain
Human medicine
Field of application
LODOCO ist indiziert, um das Risiko von Myokardinfarkt, Schlaganfall, koronarer Revaskularisation und kardiovaskulärem Tod bei erwachsenen Patienten mit etablierten atherosklerotischen Erkrankungen oder mit mehreren Risikofaktoren für kardiovaskuläre Erkrankungen zu verringern.

Packaging details

Description (FR)
LODOCO cpr 0.5 mg 30 pce
Description (DE)
LODOCO Tabl 0.5 mg 30 Stk
Market launch
01/04/2026
Narcotic (BTM)
No
Buy us a coffee Explore the data